| Ytd | 65.29% | |
| 1y | 177.57% |
| Open | 39.80 | Prev Close | 40.09 | Low | 39.67 | High | 40.58 | Mkt Cap | 2.73B |
| Vol | 88.53K | Avg Vol | 2.13M | EPS | -3.48 | P/E | -11.52 | Forward P/E | 27.93 |
| Beta | 0.90 | Short Ratio | 8.60 | Inst. Own | 90.04% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 34.68 | 200-d Avg | 29.28 | 1yr Est | 64.81 |
~ uniQure to host earnings call on Wednesday, July 29, 2026 at 8:30 a.m. ET ~ ~ uniQure to host earn
QURE is sharpening its gene therapy focus through faster regulatory pathways, a streamlined business
QURE has soared on renewed AMT-130 optimism, but rich valuation, uneven earnings and pending regulat
QURE's AMT-130 is driving investor focus as FDA feedback, a targeted third-quarter 2026 filing and c
Top Wall Street analysts upgraded and downgraded several top companies, including Applied Materials,
HC Wainwright & Co. analyst Patrick R. Trucchio maintains uniQure (NASDAQ:QURE) with a Buy an
Capricor stock falls after the FDA schedules a July advisory committee meeting for Deramiocel, its D
Mizuho analyst Uy Ear maintains uniQure (NASDAQ:QURE) with a Outperform and raises the price targ
Dow Jones index fell 200+ points on Monday. Backblaze Inc rose 30.4% after $335M data storage deal w
uniQure reported early seizure reductions in an AMT-260 epilepsy study, with no treatment-related se
FDA reverses its rejection of Regenxbio Navsunli, allowing the company to refile its gene therapy ap
U.S. stocks up, Dow Jones gains 0.39%. NASDAQ rose 0.09%, S&P 500 up 0.11%. Industrials shares j
U.S. stocks rose, with the Dow Jones gaining 200 points on Wed. Jabil Inc (JBL) shares surged 9.8% a
US stocks up, Dow Jones up 171 pts. Replimune Group rises after FDA agreement. Other big gainers inc
Top Wall Street analysts changed their outlook on top names. See all changes on analyst ratings page
Wall Street analysts upgraded Uniqure NV, Apyx Medical Inc, J M Smucker Co, and VTEX with raised pri
FDA biologics chief Vinay Prasad will leave in April, lifting biotech stocks such as uniQure, Capric
US stocks tumble as Dow falls 650 points. Relmada Therapeutics stock rises 40.8% on promising cancer
Editor’s Note: The future prices of benchmark tracking ETFs and the headline were updated in the sto
uniQure (QURE) stock surges following news of CBER director Vinay Prasad's exit. See why the mar
Lisata Therapeutics (LSTA) surged 20.3% to $5.03 in pre-market trading after agreeing to be taken pr
Dow Jones falls 500 points on Friday, Marvell Technology shares jump 18.4%, other stocks recording g
Stocks fall in US, Dow drops 150 points. Energy sector up, consumer discretionary down. ISM and S&a
Jim Cramer recommends caution with Ambiq Micro (AMBQ) and suggests Broadcom (AVGO). He dislikes Albe
On Monday, 369 companies set new 52-week lows.
During Thursday's session, 406 companies made new 52-week lows.